XML 42 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity (Details Textual) - USD ($)
1 Months Ended 6 Months Ended 12 Months Ended
Jan. 06, 2020
Jan. 14, 2019
Aug. 09, 2016
Dec. 13, 2013
Jan. 31, 2020
Jan. 31, 2019
Jun. 30, 2020
Dec. 31, 2019
Mar. 31, 2020
Stockholders' Equity (Textual)                  
Preferred stock, shares authorized             5,000,000 5,000,000  
Preferred stock, par value             $ 0.001 $ 0.001  
Number of options outstanding, granted             125,000    
Preferred Stock [Member]                  
Stockholders' Equity (Textual)                  
Preferred stock, shares authorized       5,000,000          
Preferred stock, par value       $ 0.001          
Preferred stock, voting rights description       The holders of the preferred stock are entitled to fifty (50) votes for each share held          
Preferred stock outstanding transactions description       At least 51% of the total number of shares of Preferred Stock outstanding.          
Shares per price       $ 1.00          
Directors [Member]                  
Stockholders' Equity (Textual)                  
Stock-based compensation expense         $ 24,200 $ 31,100      
Common stock price per share         $ 0.22 $ 0.311      
Common stock issued for services, shares 110,000 100,000              
Common stock issued for services, fair value         $ 24,200 $ 31,100      
2016 Plan [Member]                  
Stockholders' Equity (Textual)                  
Issued shares of common stock, shares     10,000,000            
Future issuance shares             9,835,000 9,960,000  
Stock option awards               40,000 165,000
Stock option exercisable               40,000 75,000
2014 Plan [Member]                  
Stockholders' Equity (Textual)                  
Number of options outstanding, granted     1,250,000            
Number of vested shares     1,250,000            
Issued shares of common stock, shares     1,250,000            
Terms of plan     The Company also continues to maintain its 2014 Equity Compensation Plan (the "2014 Plan"), pursuant to which 1,250,000 previously awarded stock options are outstanding. The 2014 Plan has been superseded by the 2016 Plan. Accordingly, no additional shares subject to the existing 2014 Plan will be issued and the 1,250,000 shares issuable upon exercise of stock options will be issued pursuant to the 2014 Plan, if exercised.            
Stock option exercisable             1,125,000 1,125,000  
Stock option to purchase             $ 1,250,000 $ 1,250,000  
Stock options [Member]                  
Stockholders' Equity (Textual)                  
Purchase of common stock 125,000                
Stock option grant date Jan. 06, 2020                
Shares per price               $ 0.13  
Sale of stock, description (i) 35,000 of such shares on January 6, 2020, and (ii) as to 10,000 of such shares on January 6, 2021 and each year thereafter through January 6, 2029. The fair value of this option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions: dividend yield of 0%; expected volatility of 110%; risk-free interest rate of 1.81%; and, an estimated holding period of 10 years. In connection with these options, the Company valued these options at a fair value of $23,388 and will record stock-based compensation expense over the vesting period.                
Stock-based compensation expense             $ 18,036 $ 11,806  
Number of options outstanding, granted             1,415,000 1,200,000  
Exercise price $ 1.00                
Unvested stock-based compensation expense             $ 53,195    
Options expiration date Jan. 06, 2030